查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2130631

下一代透析設備市場分析與預測（至2035年）：類型、產品類型、服務、技術、組件、應用、最終用戶、功能、安裝配置、解決方案

Next Gen Dialysis Machines Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Component, Application, End User, Functionality, Installation Type, Solutions
出版日期: | 出版商: Global Insight Services | 英文 350 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

全球新一代透析設備市場預計將從2025年的5.156億美元成長到2035年的7.065億美元，複合年成長率（CAGR）為3.2%。腎臟病患者數量的持續成長支撐了對新一代透析設備的需求。根據世界衛生組織（WHO）估計，到2026年，全球將有約6.74億人患有慢性腎臟病，這是一種腎衰竭狀態，需要透析或腎臟移植來維持生命。在美國，根據美國國家糖尿病、消化和腎臟疾病研究所（NIDDK）的數據，大約每1,000名美國人中就有2人患有末期腎病，需要透析或腎臟移植。 2025年美國腎臟數據系統（USRDS）年度數據報告繼續提供專門的資料集，涵蓋末期腎功能衰竭（ESRD）的治療、患者特徵、醫療服務提供者、醫療成本和國際比較。隨著人們越來越重視居家照護、便攜性、自動化和資源高效的透析方式，這些指標構成了對設備持續需求的基礎。

該產品領域不僅包括傳統的體外透析系統，還包括新興的緊湊型、以患者為中心的透析平台。血液透析仍然是一項核心技術，它利用透析器和可控的血液及透析液流速，在臨床環境中實現高效的溶質清除。腹膜透析可自動進行腹膜內的液體交換，支持居家治療。穿戴式透析設備透過微型幫浦、吸附系統和緊湊型過濾組件，實現連續或長期治療。同時，攜帶式設備使患者能夠在傳統透析中心之外進行治療。市場需求正日益轉向能夠減輕治療負擔、提高患者活動能力、支持居家照護和個人化治療的系統，這為小型化、自動化、遠端監測和節能設計等領域創造了巨大的發展機會。

市場區隔
類型 血液透析機、腹膜透析機、攜帶式透析機、穿戴式透析設備等。
產品 獨立式透析機、整合式透析系統、透析配件等。
服務 院內透析服務、居家透析服務、遠端醫療服務、維護及維修服務等。
科技 人工智慧（AI）整合、物聯網系統、遠端監控、自動化透析系統等。
成分 透析器、血液循環系統、濃縮液和溶液等
目的 慢性腎臟病的治療、急性腎損傷的治療及其他相關領域。
最終用戶 醫院、透析診所、居家醫療及其他
功能 連續性腎臟替代療法、間歇性血液透析等。
安裝表格 固定式、攜帶式及其他類型。
解決方案 軟體解決方案、硬體解決方案及其他

該技術領域涵蓋了成熟的透析平台和先進的治療方法，其特點在於清除率、治療時間和臨床應用。傳統透析技術主要採用標準膜和控制擴散進行常規腎臟替代治療。高通量透析採用高滲透性薄膜，以增強對大分子和中等分子物質的清除，同時實現高效的體液管理和更佳的治療效果。連續性腎臟替代療法（CRRT）提供長期、持續的體外治療，特別適用於需要逐步清除體液和溶質的重症患者。技術研發日益著重於生物相容性膜、精確的超過濾控制、整合感測器、自動治療調節和網路化監測。這些進步正在拓展下一代系統在醫院、加護病房和家庭環境中的應用。

區域概覽

北美憑藉其完善的腎臟護理基礎設施、高透析利用率、先進的醫療金融體係以及廣泛的透析服務提供者網路，在下一代透析設備領域保持著強勁的地位。美國是主要的需求中心，因為擁有大量接受治療的末期腎功能衰竭（ESRD）患者，其院內和居家透析生態系統已經相當成熟。美國透析登記系統（USRDS）系統性地追蹤治療方法、服務提供者特徵、醫療成本和血管通路狀況，反映了該地區透析基礎設施的完善程度。越來越多的投資正轉向居家透析、連網型設備、小型化系統、改良膜和自動化技術。聯邦政府的品質計劃和支持居家治療的醫療政策正在鼓勵製造商開發能夠提高治療柔軟性、監測能力、安全性和患者自主性的設備。

隨著腎臟病患病率上升、人口老化、醫療基礎設施不斷完善以及腎臟替代療法的普及，亞太地區正日益成為重要的市場，這些因素持續影響著醫療器材的需求。在中國、日本、印度、韓國和其他區域市場，透析能力不斷提升，醫療服務提供者也越來越重視居家、攜帶式和資源節約型技術。各國政府致力於提高腎臟護理的可及性，並大力推動非傳染性疾病的管理，這些措施正在為治療生態系統的發展提供支持。世界衛生組織2025年腎臟健康決議呼籲各國將腎臟照護納入國家衛生策略，並加強預防、篩檢和治療服務。因此，區域製造商和國際供應商正在積極推動在地化、技術合作、臨床開發以及經濟高效的器材配置，以適應不同的醫療環境。

主要趨勢和促進因素

透析技術正朝著更聰明、更便攜、更以患者為中心的方向發展：

透析技術正朝著以患者為中心、網路化且日益便攜的治療平台發展，該平台融合了小型化硬體、自動化液體管理、先進膜、嵌入式感測器和遠端臨床監測。製造商正致力於研發居家透析系統，以提高治療的柔軟性和患者的活動能力，同時減少對大規模透析中心的依賴。穿戴式和可攜式系統仍然是重要的創新方向，而互聯監測則使臨床醫生能夠遠端評估治療參數、識別異常情況並支援個人化治療。這一轉變也推動了小容量系統、簡化介面、基於吸附劑的再生技術以及智慧控制架構的開發，從而支持更連續的腎臟替代療法。

腎衰竭負擔日益加重，推動了先進透析技術的應用。

慢性腎臟病和腎衰竭帶來的日益沉重的臨床和醫療保健系統負擔，推動了對更便利、更有效率的腎臟替代技術的需求。世界衛生組織指出，糖尿病、高血壓、心血管疾病和人口老化是導致腎臟疾病負擔加重的關鍵因素。同時，醫療保健系統也在尋求能夠減輕基礎設施負擔、擴大治療覆蓋範圍並提高患者便利性的替代方案。隨著家庭透析的日益普及，以及醫療服務提供者不斷努力改進透析項目和提升護理質量，攜帶式透析設備、自動化腹膜透析平台、遠端監測和小型血液透析系統等領域的投資正在不斷成長。這些需求正在加速傳統醫療機構設備以外的創新發展。

目錄

第1章：摘要整理

第2章 市場亮點

第3章 市場動態

  • 宏觀經濟分析
  • 市場趨勢
  • 市場促進因素
  • 市場機遇
  • 市場限制因素
  • 複合年均成長率分析
  • 影響分析
  • 新興市場
  • 技術藍圖
  • 戰略框架

第4章：細分市場分析

  • 市場規模及預測：依類型
    • 血液透析機
    • 腹膜透析機
    • 攜帶式透析機
    • 穿戴式透析設備
    • 其他
  • 市場規模及預測：依產品分類
    • 獨立式透析機
    • 一體化透析系統
    • 透析配件
    • 其他
  • 市場規模及預測：依服務分類
    • 院內透析服務
    • 居家透析服務
    • 遠端醫療服務
    • 維護和維修服務
    • 其他
  • 市場規模及預測：依技術分類
    • 人工智慧（AI）的整合
    • 物聯網系統
    • 遠端監控
    • 自動化透析系統
    • 其他
  • 市場規模及預測：依組件分類
    • 透析機
    • 血液循環系統
    • 濃縮液和溶液
    • 其他
  • 市場規模及預測：依應用領域分類
    • 慢性腎臟病的治療
    • 急性腎損傷的治療
    • 其他
  • 市場規模及預測：依最終用戶分類
    • 醫院
    • 透析診所
    • 居家醫療
    • 其他
  • 市場規模及預測：依功能分類
    • 持續腎臟替代療法
    • 間歇性血液透析
    • 其他
  • 市場規模及預測：依安裝類型分類
    • 固定安裝
    • 移動安裝
    • 其他
  • 市場規模及預測：按解決方案分類
    • 軟體解決方案
    • 硬體解決方案
    • 其他

第5章 區域分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲國家
  • 亞太地區
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲
    • 台灣
    • 其他亞太國家
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 其他歐洲國家
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 撒哈拉以南非洲
    • 其他中東和非洲國家

第6章 市場策略

  • 供需差距分析
  • 貿易和物流限制
  • 價格、成本和利潤率趨勢
  • 市場滲透率
  • 消費者分析
  • 監管概述

第7章 競爭訊息

  • 市場定位
  • 市場占有率
  • 競爭基準
  • 大公司的策略

第8章：公司簡介

  • Fresenius Medical Care
  • Baxter International
  • Nipro Corporation
  • B. Braun Melsungen
  • Asahi Kasei Corporation
  • DaVita Inc
  • Medtronic
  • Nikkiso Co Ltd
  • Toray Medical Co Ltd
  • NxStage Medical
  • Quanta Dialysis Technologies
  • Outset Medical
  • Dialife Group
  • AWAK Technologies
  • JMS Co Ltd
  • Medica SpA
  • Rockwell Medical
  • Kawasumi Laboratories
  • SWS Hemodialysis Care Co Ltd
  • Medionics International

第9章 關於我們

簡介目錄
Product Code: GIS11037

The global Next Gen Dialysis Machines Market is projected to grow from $515.6 Million in 2025 to $706.5 Million by 2035, at a compound annual growth rate (CAGR) of 3.2%. The demand base for next-generation dialysis equipment is supported by a substantial and expanding kidney-disease population. WHO reported an estimated 674 million people living with chronic kidney disease globally in 2026, with kidney failure requiring dialysis or transplantation to sustain life. In the United States, NIDDK reports that approximately 2 in 1,000 Americans live with end-stage kidney disease treated through dialysis or transplantation. The 2025 USRDS Annual Data Report continues to provide dedicated datasets covering ESRD treatment modalities, patient characteristics, providers, expenditures, and international comparisons. These indicators underpin sustained equipment demand while increasing emphasis on home treatment, portability, automation, and resource-efficient dialysis delivery.

The type segment encompasses conventional extracorporeal systems alongside emerging compact and patient-centric platforms. Hemodialysis machines remain the core technology, using dialyzers and controlled blood and dialysate flows to provide efficient solute clearance in clinical settings. Peritoneal dialysis machines automate fluid exchange through the peritoneal membrane and support home-based treatment. Wearable dialysis machines target continuous or extended therapy through miniaturized pumps, sorbent systems, and compact filtration components, while portable machines enable treatment outside conventional dialysis centers. Demand is increasingly shifting toward systems that reduce treatment burden, improve mobility, enable home care, and support personalized therapy, creating strong development opportunities for miniaturization, automation, remote monitoring, and energy-efficient designs.

Market Segmentation
TypeHemodialysis Machines, Peritoneal Dialysis Machines, Portable Dialysis Machines, Wearable Dialysis Devices, Others
ProductStandalone Dialysis Machines, Integrated Dialysis Systems, Dialysis Accessories, Others
ServicesIn-Center Dialysis Services, Home Dialysis Services, Telehealth Services, Maintenance and Repair Services, Others
TechnologyArtificial Intelligence Integration, IoT-Enabled Systems, Remote Monitoring, Automated Dialysis Systems, Others
ComponentDialyzers, Bloodline Systems, Concentrates and Solutions, Others
ApplicationChronic Kidney Disease Treatment, Acute Kidney Injury Management, Others
End UserHospitals, Dialysis Clinics, Home Care Settings, Others
FunctionalityContinuous Renal Replacement Therapy, Intermittent Hemodialysis, Others
Installation TypeFixed Installation, Mobile Installation, Others
SolutionsSoftware Solutions, Hardware Solutions, Others

The technology segment includes established dialysis platforms and advanced modalities differentiated by clearance performance, treatment duration, and clinical application. Conventional dialysis technology primarily uses standard membranes and controlled diffusion for routine renal replacement. High-flux dialysis employs highly permeable membranes to enhance removal of larger middle molecules while supporting efficient fluid management and improved treatment performance. CRRT provides prolonged, continuous extracorporeal therapy and is particularly suited to critically ill patients requiring gradual fluid and solute removal. Technological development is increasingly focused on biocompatible membranes, precise ultrafiltration control, integrated sensors, automated treatment adjustment, and connected monitoring. These advances are expanding the role of next-generation systems across hospitals, intensive-care units, and home environments.

Geographical Overview

North America maintains a strong position in next-generation dialysis machines because of its established renal-care infrastructure, high dialysis utilization, advanced healthcare financing systems, and extensive network of dialysis providers. The United States represents the principal demand center, supported by a large treated ESRD population and mature in-center and home dialysis ecosystems. USRDS systematically tracks treatment modalities, provider characteristics, expenditures, and vascular access, reflecting the depth of the regional dialysis infrastructure. Investment is increasingly directed toward home dialysis, connected devices, compact systems, improved membranes, and automation. Federal quality programs and healthcare policies supporting home modalities are encouraging manufacturers to develop equipment capable of improving treatment flexibility, monitoring, safety, and patient independence.

Asia Pacific is becoming an increasingly important market as kidney-disease prevalence, aging populations, healthcare infrastructure expansion, and access to renal replacement therapy continue to influence equipment demand. China, Japan, India, South Korea, and other regional markets are expanding dialysis capacity while healthcare providers increasingly evaluate home-based, portable, and resource-efficient technologies. Government efforts to strengthen kidney-care access and broader noncommunicable-disease management are supporting the treatment ecosystem. WHO's 2025 kidney-health resolution called for countries to integrate kidney care into national health strategies and strengthen prevention, detection, and treatment services. Regional manufacturers and international suppliers are consequently pursuing localization, technology partnerships, clinical development, and lower-cost equipment configurations to address diverse healthcare environments.

Key Trends and Drivers

Dialysis Goes Smart, Portable, and Patient Centric:

Dialysis technology is moving toward patient-centric, connected, and increasingly portable treatment platforms that combine miniaturized hardware, automated fluid management, advanced membranes, embedded sensors, and remote clinical supervision. Manufacturers are emphasizing home-compatible designs that reduce dependence on large dialysis centers while improving treatment flexibility and patient mobility. Wearable and portable systems remain an important innovation pathway, while connected monitoring enables clinicians to evaluate treatment parameters remotely, identify abnormalities, and support personalized therapy. This transition is also encouraging development of lower-volume systems, simplified interfaces, sorbent-based regeneration, and intelligent control architectures capable of supporting more continuous forms of renal replacement therapy.

Rising Kidney Failure Burden Fuels Advanced Dialysis Adoption:

The increasing clinical and healthcare-system burden associated with chronic kidney disease and kidney failure is strengthening demand for more accessible and efficient renal replacement technologies. WHO identifies diabetes, hypertension, cardiovascular disease, and population aging among important factors associated with the rising kidney-disease burden. At the same time, healthcare systems are seeking alternatives that can reduce infrastructure pressure, expand treatment access, and improve patient convenience. Growing acceptance of home dialysis, supported by healthcare-provider programs and treatment-quality initiatives, is encouraging investment in portable machines, automated peritoneal dialysis platforms, remote monitoring, and compact hemodialysis systems. These requirements are accelerating innovation beyond conventional center-based equipment.

Research Scope

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Component
  • 2.6 Key Market Highlights by Application
  • 2.7 Key Market Highlights by End User
  • 2.8 Key Market Highlights by Functionality
  • 2.9 Key Market Highlights by Installation Type
  • 2.10 Key Market Highlights by Solutions

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Hemodialysis Machines
    • 4.1.2 Peritoneal Dialysis Machines
    • 4.1.3 Portable Dialysis Machines
    • 4.1.4 Wearable Dialysis Devices
    • 4.1.5 Others
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Standalone Dialysis Machines
    • 4.2.2 Integrated Dialysis Systems
    • 4.2.3 Dialysis Accessories
    • 4.2.4 Others
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 In-Center Dialysis Services
    • 4.3.2 Home Dialysis Services
    • 4.3.3 Telehealth Services
    • 4.3.4 Maintenance and Repair Services
    • 4.3.5 Others
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Artificial Intelligence Integration
    • 4.4.2 IoT-Enabled Systems
    • 4.4.3 Remote Monitoring
    • 4.4.4 Automated Dialysis Systems
    • 4.4.5 Others
  • 4.5 Market Size & Forecast by Component (2020-2035)
    • 4.5.1 Dialyzers
    • 4.5.2 Bloodline Systems
    • 4.5.3 Concentrates and Solutions
    • 4.5.4 Others
  • 4.6 Market Size & Forecast by Application (2020-2035)
    • 4.6.1 Chronic Kidney Disease Treatment
    • 4.6.2 Acute Kidney Injury Management
    • 4.6.3 Others
  • 4.7 Market Size & Forecast by End User (2020-2035)
    • 4.7.1 Hospitals
    • 4.7.2 Dialysis Clinics
    • 4.7.3 Home Care Settings
    • 4.7.4 Others
  • 4.8 Market Size & Forecast by Functionality (2020-2035)
    • 4.8.1 Continuous Renal Replacement Therapy
    • 4.8.2 Intermittent Hemodialysis
    • 4.8.3 Others
  • 4.9 Market Size & Forecast by Installation Type (2020-2035)
    • 4.9.1 Fixed Installation
    • 4.9.2 Mobile Installation
    • 4.9.3 Others
  • 4.10 Market Size & Forecast by Solutions (2020-2035)
    • 4.10.1 Software Solutions
    • 4.10.2 Hardware Solutions
    • 4.10.3 Others

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Component
      • 5.2.1.6 Application
      • 5.2.1.7 End User
      • 5.2.1.8 Functionality
      • 5.2.1.9 Installation Type
      • 5.2.1.10 Solutions
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Component
      • 5.2.2.6 Application
      • 5.2.2.7 End User
      • 5.2.2.8 Functionality
      • 5.2.2.9 Installation Type
      • 5.2.2.10 Solutions
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Component
      • 5.2.3.6 Application
      • 5.2.3.7 End User
      • 5.2.3.8 Functionality
      • 5.2.3.9 Installation Type
      • 5.2.3.10 Solutions
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Component
      • 5.3.1.6 Application
      • 5.3.1.7 End User
      • 5.3.1.8 Functionality
      • 5.3.1.9 Installation Type
      • 5.3.1.10 Solutions
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Component
      • 5.3.2.6 Application
      • 5.3.2.7 End User
      • 5.3.2.8 Functionality
      • 5.3.2.9 Installation Type
      • 5.3.2.10 Solutions
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Component
      • 5.3.3.6 Application
      • 5.3.3.7 End User
      • 5.3.3.8 Functionality
      • 5.3.3.9 Installation Type
      • 5.3.3.10 Solutions
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Component
      • 5.4.1.6 Application
      • 5.4.1.7 End User
      • 5.4.1.8 Functionality
      • 5.4.1.9 Installation Type
      • 5.4.1.10 Solutions
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Component
      • 5.4.2.6 Application
      • 5.4.2.7 End User
      • 5.4.2.8 Functionality
      • 5.4.2.9 Installation Type
      • 5.4.2.10 Solutions
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Component
      • 5.4.3.6 Application
      • 5.4.3.7 End User
      • 5.4.3.8 Functionality
      • 5.4.3.9 Installation Type
      • 5.4.3.10 Solutions
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Component
      • 5.4.4.6 Application
      • 5.4.4.7 End User
      • 5.4.4.8 Functionality
      • 5.4.4.9 Installation Type
      • 5.4.4.10 Solutions
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Component
      • 5.4.5.6 Application
      • 5.4.5.7 End User
      • 5.4.5.8 Functionality
      • 5.4.5.9 Installation Type
      • 5.4.5.10 Solutions
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Component
      • 5.4.6.6 Application
      • 5.4.6.7 End User
      • 5.4.6.8 Functionality
      • 5.4.6.9 Installation Type
      • 5.4.6.10 Solutions
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Component
      • 5.4.7.6 Application
      • 5.4.7.7 End User
      • 5.4.7.8 Functionality
      • 5.4.7.9 Installation Type
      • 5.4.7.10 Solutions
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Component
      • 5.5.1.6 Application
      • 5.5.1.7 End User
      • 5.5.1.8 Functionality
      • 5.5.1.9 Installation Type
      • 5.5.1.10 Solutions
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Component
      • 5.5.2.6 Application
      • 5.5.2.7 End User
      • 5.5.2.8 Functionality
      • 5.5.2.9 Installation Type
      • 5.5.2.10 Solutions
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Component
      • 5.5.3.6 Application
      • 5.5.3.7 End User
      • 5.5.3.8 Functionality
      • 5.5.3.9 Installation Type
      • 5.5.3.10 Solutions
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Component
      • 5.5.4.6 Application
      • 5.5.4.7 End User
      • 5.5.4.8 Functionality
      • 5.5.4.9 Installation Type
      • 5.5.4.10 Solutions
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Component
      • 5.5.5.6 Application
      • 5.5.5.7 End User
      • 5.5.5.8 Functionality
      • 5.5.5.9 Installation Type
      • 5.5.5.10 Solutions
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Component
      • 5.5.6.6 Application
      • 5.5.6.7 End User
      • 5.5.6.8 Functionality
      • 5.5.6.9 Installation Type
      • 5.5.6.10 Solutions
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Component
      • 5.6.1.6 Application
      • 5.6.1.7 End User
      • 5.6.1.8 Functionality
      • 5.6.1.9 Installation Type
      • 5.6.1.10 Solutions
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Component
      • 5.6.2.6 Application
      • 5.6.2.7 End User
      • 5.6.2.8 Functionality
      • 5.6.2.9 Installation Type
      • 5.6.2.10 Solutions
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Component
      • 5.6.3.6 Application
      • 5.6.3.7 End User
      • 5.6.3.8 Functionality
      • 5.6.3.9 Installation Type
      • 5.6.3.10 Solutions
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Component
      • 5.6.4.6 Application
      • 5.6.4.7 End User
      • 5.6.4.8 Functionality
      • 5.6.4.9 Installation Type
      • 5.6.4.10 Solutions
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Component
      • 5.6.5.6 Application
      • 5.6.5.7 End User
      • 5.6.5.8 Functionality
      • 5.6.5.9 Installation Type
      • 5.6.5.10 Solutions

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Fresenius Medical Care
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Baxter International
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Nipro Corporation
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 B. Braun Melsungen
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Asahi Kasei Corporation
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 DaVita Inc
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Medtronic
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Nikkiso Co Ltd
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Toray Medical Co Ltd
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 NxStage Medical
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Quanta Dialysis Technologies
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Outset Medical
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Dialife Group
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 AWAK Technologies
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 JMS Co Ltd
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Medica SpA
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 Rockwell Medical
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Kawasumi Laboratories
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 SWS Hemodialysis Care Co Ltd
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Medionics International
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us